ArticleActa pharmaceutica Sinica. B2021
An optimized derivative of an endogenous CXCR4 antagonist prevents atopic dermatitis and airway inflammation.
Mirja Harms et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this papercites it